Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Aktionär | Typ | Gehalten (Tatsächlich) | % Ausstehender Aktien | Marktwert | Positionsdatum |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | Institution | 12.198.625 | 20,51% | US$ 354,61M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 10.259.291 | 17,25% | US$ 298,24M | 2026-03-04 |
| FMR LLC | Institution | 7.747.629 | 13,03% | US$ 225,22M | 2026-03-31 |
| Nextech Invest Ltd. | Institution | 4.055.861 | 6,82% | US$ 117,90M | 2026-03-31 |
| Nextech IV Oncology S.C.S. SICAV-SIF | Institution | 4.055.861 | 6,82% | US$ 117,90M | 2024-09-30 |
| Janus Henderson Group plc | Institution | 3.890.589 | 6,54% | US$ 113,10M | 2026-03-31 |
| Alta Partners LP | Institution | 3.823.425 | 6,43% | US$ 111,15M | 2026-03-31 |
| Alta Partners Nextgen Fund II, L.P. | Institution | 3.823.425 | 6,43% | US$ 111,15M | 2025-12-19 |
| Farallon Capital Management, L.L.C. | Institution | 3.580.818 | 6,02% | US$ 104,09M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 3.248.980 | 5,46% | US$ 94,45M | 2026-03-31 |
| The Column Group, LLC | Institution | 2.898.103 | 4,87% | US$ 84,25M | 2025-02-27 |
| TCG Crossover Fund I, L.P. | Institution | 2.898.103 | 4,87% | US$ 84,25M | 2025-02-27 |
| Commodore Capital Master LP | Institution | 2.750.000 | 4,62% | US$ 79,94M | 2025-05-07 |
| Commodore Capital LP | Institution | 2.475.000 | 4,16% | US$ 71,95M | 2026-03-31 |
| BlackRock, Inc. | Institution | 2.217.747 | 3,73% | US$ 64,47M | 2026-03-31 |
| Paradigm Biocapital Advisors LP | Institution | 2.054.991 | 3,46% | US$ 59,74M | 2026-03-31 |
| BVF Partners L.P. | Institution | 1.976.196 | 3,32% | US$ 57,45M | 2026-03-31 |
| RA Capital Nexus Fund, L.P. | Institution | 1.496.613 | 2,52% | US$ 43,51M | 2026-03-04 |
| Farallon Capital Offshore Investors II, L.P | Institution | 1.452.596 | 2,44% | US$ 42,23M | 2026-03-31 |
| Dr. Todd Harris | Insider | 1.358.631 | 2,28% | US$ 39,50M | 2026-05-05 |
| Caligan Partners, LP | Institution | 1.276.968 | 2,15% | US$ 37,12M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1.216.078 | 2,04% | US$ 35,35M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 1.135.053 | 1,91% | US$ 33,00M | 2025-12-31 |
| Vanguard Capital Management, LLC | Institution | 1.125.970 | 1,89% | US$ 32,73M | 2026-03-31 |
| 5AM Venture Management, LLC | Institution | 1.029.298 | 1,73% | US$ 29,92M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 986.061 | 1,66% | US$ 28,66M | 2026-03-31 |
| Logos Global Management, L.P. | Institution | 850.000 | 1,43% | US$ 24,71M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 829.908 | 1,40% | US$ 24,13M | 2025-12-31 |
| Barclays PLC | Institution | 808.077 | 1,36% | US$ 23,49M | 2026-03-31 |
| Canaan Management, Inc. | Institution | 750.000 | 1,26% | US$ 21,80M | 2026-03-31 |
| Canaan XI | Institution | 750.000 | 1,26% | US$ 21,80M | 2026-03-31 |
| Farallon Capital Institutional Partners, L.P. | Institution | 739.107 | 1,24% | US$ 21,49M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 658.482 | 1,11% | US$ 19,14M | 2026-03-31 |
| Jennison Associates LLC | Institution | 632.432 | 1,06% | US$ 18,38M | 2026-03-31 |
| Sio Capital Management, LLC | Institution | 605.439 | 1,02% | US$ 17,60M | 2026-03-31 |
| Farallon Capital Partners, L.P. | Institution | 579.376 | 0,97% | US$ 16,84M | 2026-03-31 |
| Deerfield Management Company, L.P. | Institution | 549.000 | 0,92% | US$ 15,96M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 526.604 | 0,89% | US$ 15,31M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 351.479 | 0,59% | US$ 10,22M | 2026-03-31 |
| Elmind Capital, L.P. | Institution | 350.000 | 0,59% | US$ 10,17M | 2026-03-31 |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
